NL-OMON31661已完成不适用
Population pharmacokinetics/pharmacodynamics of Propofol in morbidly obese patients - POP
anesthesiologie0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Morbidly obese patients with a Body Mass Index > 40 undergoing laparoscopic banding or gastric bypass surgery, 18-60 year old.
排除标准
- •Epilepsy, pregnancy, breastfeeding and known allergy for Propofol, egg lecithin or soy bean oil.
研究者
相似试验
进行中（未招募）
不适用
Population pharmacokinetics/pharmacodynamics of Propofol in morbidly obese patients - POPThe study is performed in order to develop a population pharmacokinetic and pharmacodynamic model of Propofol when used for induction and maintenance of anaesthesia in the morbidly obese patient (BMI > 40).EUCTR2006-005670-45-NLSt. Antonius hospital Nieuwegein
尚未招募
4 期
Childhood obesity and propofol infusioChildhood obesityAnaesthesiology - Other anaesthesiologyDiet and Nutrition - ObesityACTRN12611000451909Auckland City Hospital60
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
进行中（未招募）
1 期
Is treatment with the painkiller paracetamol safe in patients with spinal muscular atrophy and cerebral palsy?Spinal muscular atrophy type II (SMA II)Cerebral palsy (CP)EUCTR2018-002295-40-DKCopenhagen Neuromuscular Center24
进行中（未招募）
不适用
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20